FREE PAPER B O‐05: Sorafenib interferes with signaling events important for NTCP‐mediated HBV/HDV uptake

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|3-3

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HDV2 O‐09: REP 2139 monotherapy and combination therapy with pegylated interferon: safety and potent reduction of HBsAg and HDV RNA in Caucasian Patients with chronic HBV/HDV co‐infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 5-6

John Wiley & Sons Inc

Access to resources Recommend Favorite

O‐12: Study of the super‐infection by Hepatitis B Virus (HBV) and Hepatitis Delta Virus (HDV) in the HepaRG cell model

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 7-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nuclear factor kappa B–mediated CD47 up‐regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 534-545

John Wiley & Sons Inc

Access to resources Recommend Favorite

HBV promotes the proliferation of hepatic stellate cells via the PDGF-B/PDGFR-β signaling pathway in vitro

By                

International Journal of Molecular Medicine, Vol. 30, Iss. 6, 2012-01 ,pp. : 1443-1450

Spandidos Publications

Access to resources Recommend Favorite

The NTCP‐inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 341-348

John Wiley & Sons Inc

Access to resources Recommend Favorite